Related Experiment Videos
Glycogenolytic effect of pancreastatin in the rat
V Sanchez1, J R Calvo, R Goberna
1Department of Medical Biochemistry and Molecular Biology, School of Medicine, University of Sevilla, Spain.
Abstract:
Pancreastatin is a novel 49-amino acid peptide with a C-terminal glycine amide. The peptide was isolated from porcine pancreatic extracts and shows a structural similarity to chromogranin A. The effect of synthetic porcine pancreastatin on blood glucose levels and hepatic glycogen content was investigated in rats in vivo. Pancreastatin (300 pmol/kg) produced a time-dependent decrease in glycogen content of liver and a slight hyperglycemia. Basal plasma insulin and glucagon levels were not modified by pancreastatin. We suggest that pancreastatin could play a biological role in the glucose metabolism through a glycogenolytic effect.